» Articles » PMID: 8292452

Reassessment of Quantitative Thallium-201 Brain SPECT for Miscellaneous Brain Tumors

Overview
Journal Ann Nucl Med
Date 1993 Nov 1
PMID 8292452
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In order to reassess the value of quantitative thallium-201 brain SPECT in the differentiation of miscellaneous brain tumors, we studied a total of 89 patients--35 pre-operative patients suspected of having a brain tumor and 54 post-operative patients with a brain tumor. We came to the conclusion that quantitative Tl-201 brain SPECT was very useful in discriminating cerebral radiation necrosis from recurrent tumor, estimating residual tumor burden, and detecting tumor regrowth earlier in postoperative patients. In preoperative patients, however, Tl-201 SPECT cannot be used effectively to differentiate glioma from other intracranial tumors, although intense uptake of Tl-201 may provide evidence of glioblastoma or a hypervascular lesion.

Citing Articles

Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.

Yamauchi M, Okada T, Okada T, Yamamoto A, Fushimi Y, Arakawa Y Medicine (Baltimore). 2017; 96(33):e7767.

PMID: 28816956 PMC: 5571693. DOI: 10.1097/MD.0000000000007767.


Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?.

Shah A, Snelling B, Bregy A, Patel P, Tememe D, Bhatia R J Neurooncol. 2013; 112(2):141-52.

PMID: 23344789 DOI: 10.1007/s11060-013-1059-9.


Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.

Amin A, Moustafa H, Ahmed E, El-Toukhy M J Neurooncol. 2011; 106(3):579-87.

PMID: 21912937 DOI: 10.1007/s11060-011-0694-2.


MRI and thallium-201 SPECT in the prediction of survival in glioma.

Vos M, Berkhof J, Hoekstra O, Bosma I, Sizoo E, Heimans J Neuroradiology. 2011; 54(6):539-46.

PMID: 21755329 DOI: 10.1007/s00234-011-0908-5.


Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas.

Takeda T, Nakano T, Asano K, Shimamura N, Ohkuma H Neuroradiology. 2011; 53(11):867-73.

PMID: 21221558 DOI: 10.1007/s00234-010-0822-2.


References
1.
Kim K, Black K, Marciano D, Mazziotta J, Guze B, Grafton S . Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med. 1990; 31(6):965-9. View

2.
Kaplan W, Takvorian T, Morris J, RUMBAUGH C, Connolly B, Atkins H . Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med. 1987; 28(1):47-52. View

3.
Chamberlain M, Murovic J, Levin V . Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology. 1988; 38(9):1371-4. DOI: 10.1212/wnl.38.9.1371. View

4.
Tsuruda J, Kortman K, Bradley W, Wheeler D, Van Dalsem W, Bradley T . Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol. 1987; 149(1):165-71. DOI: 10.2214/ajr.149.1.165. View

5.
Mineura K, Sasajima T, Kowada M, Uesaka Y, Shishido F . Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography. J Nucl Med. 1991; 32(4):726-8. View